These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
673 related items for PubMed ID: 22526903
1. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases. Dexiang Z, Li R, Ye W, Haifu W, Yunshi Z, Qinghai Y, Shenyong Z, Bo X, Li L, Xiangou P, Haohao L, Lechi Y, Tianshu L, Jia F, Xinyu Q, Jianmin X. Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903 [Abstract] [Full Text] [Related]
2. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia. Yi JH, Kim H, Jung M, Shin SJ, Choi JS, Choi GH, Baik SH, Min BS, Kim NK, Ahn JB. Oncology; 2013 Sep; 85(5):283-9. PubMed ID: 24217184 [Abstract] [Full Text] [Related]
3. Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases. Neumann UP, Thelen A, Röcken C, Seehofer D, Bahra M, Riess H, Jonas S, Schmeding M, Pratschke J, Bova R, Neuhaus P. Surgery; 2009 Jul; 146(1):52-9. PubMed ID: 19541010 [Abstract] [Full Text] [Related]
4. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. John SK, Robinson SM, Rehman S, Harrison B, Vallance A, French JJ, Jaques BC, Charnley RM, Manas DM, White SA. Dig Surg; 2013 Jul; 30(4-6):293-301. PubMed ID: 23969407 [Abstract] [Full Text] [Related]
9. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis. Kim HR, Min BS, Kim JS, Shin SJ, Ahn JB, Rho JK, Kim NK, Rha SY. Oncology; 2011 Dec; 81(3-4):175-83. PubMed ID: 22057187 [Abstract] [Full Text] [Related]
11. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy. Sakamoto Y, Miyamoto Y, Beppu T, Nitta H, Imai K, Hayashi H, Baba Y, Yoshida N, Chikamoto A, Baba H. Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901 [Abstract] [Full Text] [Related]
13. Strategy for synchronous and multiple liver metastasis. Osada S, Imai H, Sasaki Y, Tanaka Y, Tokuyama Y, Okumura N, Nonaka K, Takahashi T, Yamaguchi K, Yoshida K. Hepatogastroenterology; 2012 Apr; 59(113):198-203. PubMed ID: 22251539 [Abstract] [Full Text] [Related]
16. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. Brandi G, Derenzini E, Falcone A, Masi G, Loupakis F, Pietrabissa A, Pinna AD, Ercolani G, Pantaleo MA, Di Girolamo S, Grazi GL, de Rosa F, Biasco G. Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458 [Abstract] [Full Text] [Related]